Tuesday, 13 January 2009

Indevus Pharmaceuticals stock

据 wsj 元月7日报导. On the deals front, large-cap Endo Pharmaceuticals agreed to acquire smaller pharmaceuticals in a deal that pays a 45% premium from the company's stock price at the close of monday'ssession.Indevus,based in Lexington,Mass.,closed up 2.28,or 74%,at 5.38.
(small stock)
No :9207

No comments:

Post a Comment